29 results on '"Furling, D"'
Search Results
2. P390 PGN-EDODM1 nonclinical data demonstrate mechanistic and meaningful activity for potential treatment of myotonic dystrophy type 1 (DM1)
3. IGF-1 induces human myotube hypertrophy by increasing cell recruitment
4. FP.44 Exploring the role of MuscleBlind-Like proteins in the regulation of CaVB1 isoform expression in adult skeletal muscle
5. MYASTHENIA & RELATED DISORDERS: P.31 Identification of new recessive mutations in synaptotagmin-2 responsible for severe and early presynaptic forms of congenital myasthenic syndrome
6. O.32Genome editing of expanded CTG repeats within the human DMPK gene reduces nuclear RNA foci in muscle of DM1 mice
7. D10 - Proteomic evaluation of Pip6a-PMO treatment for myotonic dystrophy type 1
8. Incidence and predictors of venous thromboembolism in inherited myopathies: A higher risk in myotonic dystrophy
9. P.279 - Development of a MBNLΔ decoy-based gene therapy for myotonic dystrophy
10. P.278 - CRISPR/Cas9-mediated genome editing corrects splicing alterations in myotonic dystrophy type 1
11. P.270 - Survival in myotonic dystrophy type 1 predicted by the new DM1 survival risk score
12. P.269 - Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-heart registry
13. 542 - Association between mutation size and cardiac involvement in myotonic dystrophy type 1: when size matters
14. P.362 - Correlation between mutation size and cardiac involvement in myotonic dystrophy type 1: An analysis of the DM1-heart registry
15. P22 High content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC independent pathway in myotonic dystrophy cell lines
16. L'IGF-1 induit une augmentation de la taille et du contenu en myosine des myotubes humains
17. P81 Compound screening in myotonic dystrophy
18. P74 Observations on oligo-based therapy for Myotonic Dystrophy
19. O.6 Antisense approach for myotonic dystrophy
20. G.P.12.01 Immunodetection of myotubularin in human tissues: A diagnostic tool for X-linked myotubular myopathy
21. P1-19 Dérégulation de l’épissage de Tau par MBNL1 dans une Tauopathie
22. D.P.4.09 Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles
23. D.P.4.08 P16 triggers premature senescence of congenital DM1 myoblasts
24. D.P.4.10 Muscleblind-like proteins: Similarities and differences in normal and myotonic dystrophy muscle
25. T.O.4 Ribozyme-based gene therapy reverses muscle atrophy in a mouse model of myotonic dystrophy
26. G.P.14.10 Inhibition of prostaglandin E2 (PGE2) production restores the differentiation of congenital human dystrophy myotonic type 1 (CDM1) myoblasts
27. G.P.14.09 Functional characterization of skeletal muscles in DM1 mice
28. G.P.3.01 The use of immortalised human fibroblasts from a DMD patient to test exon skipping in vivo
29. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.